Neuroendovascular Coil Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities
Discover trends, market shifts, and competitive outlooks for the neuroendovascular coil industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Neuroendovascular Coil Market Expected to Grow Between 2025 And 2029?
The scale of the neuroendovascular coil market has seen robust expansion in previous years. The market value is projected to rise from $1.29 billion in 2024 to $1.4 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. This substantial growth experienced in the historical period can be credited to several factors such as a surge in neurovascular diseases, an upward trend in the aging population, advancements in diagnostic technologies, the broadening scope of neurointerventional facilities, initiatives focusing on awareness and education, along with regulatory approvals and set standards.
The market for neuroendovascular coils is anticipated to see considerable growth in the upcoming years, expanding to a value of $1.87 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to the growth during the forecast period include a consistent increase in neurovascular complications, the enlargement of neurointerventional facilities, concentration on early detection, advancement of global healthcare infrastructure, emphasis on patient-focused care approach, and international research partnerships. Key trends during this period encompass developments in the field of detachable neuroendovascular coils, increased usage of liquid embolics, innovation in bioactive and bioabsorbable coils, the amalgamation of dual-layer coil technologies, and a focus on flow diverters for the treatment of aneurysms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13495&type=smp
What Are the Core Growth Drivers Propelling the Neuroendovascular Coil Market Forward?
The increasing occurrence of neurovascular diseases is projected to drive growth in the neuroendovascular coil market. Neurovascular diseases impact the blood vessels that supply the nervous system, which frequently leads to neurological symptoms and complications. Neuroendovascular coils are utilised to treat these diseases by inserting them into the blood vessels to seal or stabilise abnormal blood vessel structures, thereby minimising the risk of bleeding or other complications. For instance, data from the National Board of Health and Welfare (Socialstyrelsen), a Swedish governmental agency, in November 2023 showed that in 2022, there were about 26,800 stroke incidents affecting nearly 25,100 people. Among them, 12 percent died on the same day, 23 percent within 28 days, and 34 percent within one year. As such, the growing incidence of neurovascular conditions is fueling the expansion of the neuroendovascular coil market. The rise in healthcare spending is also anticipated to lend momentum to the growth of the neuroendovascular coil market. This expenditure entails money spent on medical products and services, public health initiatives, and administration. It is largely driven by factors such as an aging population, advancements in medical technology, skyrocketing pharmaceutical costs, and higher rates of chronic diseases. The increasing healthcare expenditure supports progress in neuroendovascular coil technology, stimulating invention, enhancing accessibility, and improving patient results in the management of cerebral aneurysms and vascular disorders. For instance, a forecast by the US-based academic journal Health Affairs in June 2024 shows the national healthcare spending in the U.S. is projected to increase from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, indicating a rise of approximately $249.5 billion. Therefore, the growth in healthcare expenditure is encouraging the expansion of the neuroendovascular coil market.
What Segment Types Define the Neuroendovascular Coil Market Structure?
The neuroendovascular coil market covered in this report is segmented –
1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils
2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm
3) By Application: Tumor Surgery, Medical Teaching
4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users
Subsegments:
1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations
2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13495&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Neuroendovascular Coil Market?
North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theNeuroendovascular Coil Industry Evolution?
Top businesses in the neuroendovascular coil market are striving for a competitive advantage through the creation of uniquely tailored, soft coils. These coils, including ones shaped like tetrahedrons, can significantly improve outcomes in complex aneurysm treatments by fitting in contrast to the structure of the blood vessels, minimizing risks, and enhancing patient health. Stryker Corporation, a prominent American medical tech company that produces neuroendovascular coils, unveiled the Target Tetra Detachable Coil in December 2022. Specifically designed for treating minor aneurysms, this state-of-the-art coil combines a novel tetrahedral shape with softness. It’s a dual-feature coil; the tetrahedral shape ensures stability within wide-necked aneurysms and the soft helical tail caters to smaller aneurysms. Hence, the developed coil not only retains its structural integrity but is also soft, making it an optimal solution for treating small aneurysms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report
What Is the Definition of the Neuroendovascular Coil Market?
A neuroendovascular coil is a thin wire inserted into blood vessels to block off or divert blood flow from the affected area, promoting clotting and preventing further complications. It is a medical device for treating cerebral aneurysms and other vascular abnormalities.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13495
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model